Related Experiment Video
Updated: May 8, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Stigma experienced by people with drug-resistant tuberculosis in Lagos, Nigeria: a cross-sectional study
Olusola A Adejumo1,2, Champaklal Jinabhai3, Olusoji Daniel4
1Mainland Hospital Yaba, Lagos Nigeria.
Background:
Tuberculosis (TB) stigma is one of the factors responsible for low notification rates in Nigeria, especially among people with drug-resistant TB (DR-TB). This study assessed the factors associated with stigma among people with DR-TB in Lagos, Nigeria.
Methods:
A descriptive cross-sectional study was conducted among 203 adults on DR-TB treatment. The Redwood DR-TB stigma scale was used to assess the stigma experienced by people with DR-TB. A logistic regression model was used to evaluate the factors associated with TB stigma.
Results:
The prevalence of TB stigma was 65.5%. Being male (adjusted odds ratio [aOR] 2.59 [95% confidence interval {CI} 1.03 to 6.50], p=0.042), not earning an income (aOR 2.57 [95% CI 1.84 to 7.85], p=0.039), substance use (alcohol or cigarette smoking; aOR 1.61 [95% CI 1.06 to 3.88], p=0.028) and the duration of the DR-TB diagnosis (aOR 2.72 [95% CI 1.94 to 3.83], p<0.001) were associated with stigma among people with DR-TB. Human immunodeficiency virus (HIV)-negative participants experienced TB stigma 2.4 times more (crude OR 2.4 [95% CI 1.14 to 5.04], p=0.021) than HIV-positive participants, although the relationship was not sustained in the multivariate analysis.
Conclusions:
Having identified the factors associated with stigma in this target population, it is imperative to address and control them among DR-TB patients in Lagos, Nigeria. The urgent need for stigma reduction strategies cannot be overemphasized.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

